Phil Sutton
Professor
Infection and Immunity
Murdoch Childrens Research Institute
Australia
Biography
Associate Professor Phil Sutton studied Biomedical Science at Bradford University in the UK before undertaking a PhD in Immunology at Manchester University. He moved to Australia in 1992 for his first postdoctoral position, and apart from a brief spell at Institut Pasteur de Lille in France, has been here ever since. Associate Professor Sutton has extensive experience in both academia and industry, including a period as Immunology group leader within the research and development division of CSL Limited, where he worked on vaccine development and adjuvant technologies. Associate Professor Sutton is a National Health and Medical Research Council (NHMRC) Senior Research Fellow with continuous funding from the NHRMC, Australian Research Council and industry partners and is a scientific committee member of the European Study Group on Pathogenesis and Immunology in Helicobacter Infections. He moved the Mucosal Immunology group to Murdoch Childrens in 2012. The Mucosal Immunology group is focused on examining how the host regulates bacterial pathogenesis within the gastrointestinal tract, as well as research on mucosal vaccine development.
Research Interest
Infection and immunity in cystic fibrosis
Publications
-
Ng GZ, Menheniott TR, Every AL, Stent A, Judd LM, Chionh YT, Dhar P, Komen JC, Giraud AS, Wang TC, McGuckin MA. The MUC1 mucin protects against Helicobacter pylori pathogenesis in mice by regulation of the NLRP3 inflammasome. Gut. 2016 Jul 1;65(7):1087-99.
-
Ng GZ, Sutton P. The MUC1 mucin specifically inhibits activation of the NLRP3 inflammasome. Genes and immunity. 2016 Apr 1;17(3):203-7.
-
Han JX, Ng GZ, Cecchini P, Chionh YT, Saeed MA, Næss LM, Joachim M, Blandford LE, Strugnell RA, Colaco CA, Sutton P. Heat shock protein complex vaccines induce antibodies against Neisseria meningitidis via a MyD88-independent mechanism. Vaccine. 2016 Mar 29;34(14):1704-11.
